<DOC>
	<DOCNO>NCT00003340</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness cyclophosphamide plus topotecan treating patient refractory relapse acute myelogenous leukemia .</brief_summary>
	<brief_title>Cyclophosphamide Plus Topotecan Treating Patients With Refractory Relapsed Acute Myelogenous Leukemia</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy cyclophosphamide follow topotecan patient relapse refractory acute myelogenous leukemia . II . Confirm safety tolerability combination schedule patient . OUTLINE : Patients receive cyclophosphamide intravenously 1 hour day 1 follow topotecan continuous 120 hour infusion start 12 hour completion cyclophosphamide . Treatment may repeat every 3-6 week least 2 course . PROJECTED ACCRUAL : A total 26 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven acute myelogenous leukemia bone marrow aspirate biopsy Clear evidence relapse residual disease great 5 % blast bone marrow examination great 30 % peripheral blast No active CNS leukemia Not eligible potentially curative allogeneic autologous bone marrow transplantation without surgery Must fail achieve complete remission conventional chemotherapy ( cytarabine base ) relapse within 12 month initial remission PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 6 week Hematopoietic : See Disease Characteristics Hepatic : Bilirubin le 1.6 mg/dL ( unless due disease ) Renal : Creatinine le 1.6 mg/dL ( unless due disease ) No prior hemorrhagic cystitis Other : Not pregnant Fertile patient must use effective contraception No active uncontrolled infection PRIOR CONCURRENT THERAPY : Biologic therapy : See Disease Characteristics Chemotherapy : See Disease Characteristics Recovered prior chemotherapy No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : Must recover prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
</DOC>